Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins

Vasa - Journal of Vascular Diseases

Volumn 34, Issue 3, 2005, Pages 176-180

  Berlit, P ^a   Stueper, B ^a   Fink, I ^b   Rebmann, V ^b   Hoyer, P ^b   Kreuzfelder, E ^b   Grosse Wilde, H ^b  

^a ALFRIED KRUPP KRANKENHAUS   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anticardiolipin antibodies; Antiphosphatidylserine antibodies; Antiribosomal phosphoprotein antibodies; Behcet's disease; Neuro Behcet

Indexed keywords

HLA C ANTIGEN; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NATURAL KILLER CELL; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS;

ADULT; ANTIBODIES; BEHCET SYNDROME; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PHOSPHOPROTEINS; REPRODUCIBILITY OF RESULTS; RIBOSOMAL PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 24344499135     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.34.3.176     Document Type: Article

References (28)

1. Agius MA, Chan JW, Chung S, Lee EK. Role of antiribosomal P protein antibodies in the diagnosis of lupus isolated to the central nervous system. Arch Neurol 1997; 54: 862-4.
2. Akman-Demir G, Serdaroglu P, Tasci B, and the Neuro-Behcet Study Group. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. Brain 1999; 122: 2171-82.
3. Arnett FC, Reveille JD, Moutsopoulos HM, Geogescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1196; 39: 1833-9.
4. Bevers EM, Confurius P, Dekkers DW, Harmsa M, Zwaal RF. Regulatory mechanisms of transmembrane phospholipid distrubutions and pathophysiological implications of transbilayer lipid scrambling. Lupus 1998; 7 (Suppl 2): S126-31.
5. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB. Association betwen lupus psychosis and antiribosomal P protein antibodies. N Engl J Med 1987; 317: 265-71.
6. Boyington JC, Sun PD. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 2002; 38: 1007-21.
7. El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER. Clinical features of Behcet's disease in patients in the Sultanate of Oman: the significance of antiphospholipid antibodies. Rheumatol Int 2002; 21: 176-81.
8. Fujimoto M, Sato S, Takehara K, Nojima Y, Soma Y, Kkikuchi K, Ihn H, Igarashi A, Tamaki K. Detection of antiribosomal P protein antibodies in patients with sytemic sclerosis. Br J Rheumatol 1995; 34: 908-11.
9. Goker B, Goker H. Current therapy for Behcet's disease. Am J Ther 2002; 9: 465-70.
10. Gul A. Behcet's disease: An update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (Suppl 24): S6-12.
11. International Study Group for Behcet's Disease. Criteria for Behcet's disease. Lancet 1990; 335: 1078-80.
12. Kremmer S, Kreuzfelder E, Klein R, Bontke N, Hennenberg-Quester KB, Steuhl KP, Grosse-Wilde H. Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 2001; 125: 211-5.
13. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and HLA-DQA1 typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-34.
14. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-45.
15. Onder M, Bozkurt M, Gurer MA, Gulekon A, Sezgin P, Imir T. Natural cellular cytotoxicity in Becet's disease. J Dermatol 1994; 21: 239-43.
16. Parisi L, Terracino ME, Valente GO, Calandriello E, Accorinti M, Sparado M. Pre-symptomatic neurological involvement in Behcet's disease: the diagnostic role of magnetic transcranial stimulation. Electroencephalography Clin Neurophysiology 1966; 101: 42-47.
17. Pozzi S, Longo A, Ferrara GB. HLA-B locus sequence-based typing. Tissue Antigens 1999; 53: 275-81.
18. Rumfeld WR, Morgan BP, Campwell. The ninth complement component in rheumatoid arthritis, Behcet's disease and other rheumatic diseases. Br J Rheumatol 1986; 25: 266-70.
19. Saruhan-Direskeneli G, Uyar FA, Cefle A, Onder SC, Eksioglu-Demiralp E, Kamali S, Inane M, Ocal L, Gula. Expression of KIR and C-type lectin receptors in Behcet's disease. Rheumatol 2004; 43: 423-7.
20. Serdaroglu P. Behcet's disease and the nervous sytem. J Neurol 1998; 245: 197-205.
21. Spezialetti R, Bluestein HG, Peter JB, Alexander EL. Neuropsychiatric disease in Sjogren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 1993; 95: 153-60.
22. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease. J Rheumatol 1992; 19: 588-92.
23. Tokay S, Direskeneli H, Yurdakul S, Akoglu T. Anticardiolipin antibodies in Behcet's disease: a reassessment. Rheumatology 2001; 40: 192-5.
24. Tziouzfas AG, Tzortzakis NG, Panou-Pomonis E, Boki KA, Sakarellos-Daitsiotis M, Karettlos C, Moutsopoulos HM. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 2000; 59: 99-104.
25. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153-63.
26. Yazici H, Yardakul S, Hamuryudan V. Behcet disease. Curr Opin Rheumatol 2001; 13: 18-22.
27. Zouboulis CC, Kotter I, Djawari, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stalder R, Wollina U, Proksch E, Sohnchen R, Weber H, Gollinck HP, Holzle E, Fritz K, Licht T, Orfanos CE. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med. J 1997; 38: 411-22.
28. Zouboulis CC, Buttner P, Tebbe B, Orfanos CE. Anticardiolipin antibodies in Adamantiades-Behcet disease. Br J Dermatol 1993; 128: 281-4.